[144] monday.com Ltd. SEC Filing

Rhea-AI Filing Summary

monday.com Ltd. (MNDY) filing reports a proposed sale under Rule 144 of 15,000 ordinary shares through Oppenheimer & Co., with an aggregate market value of $2,905,350.00 and an approximate sale date of 10/01/2025 on Nasdaq. The filer acquired 851,000 shares by exercising options on 03/07/2016, paying cash upon exercise. The notice also discloses recent dispositions by the same person totaling 37,648 shares sold between July and September 2025, generating gross proceeds of $9,508,460.10. The filer certifies no undisclosed material adverse information and references Rule 10b5-1 language where applicable.

Positive

• Clear disclosure of broker, number of shares, market value, and planned sale date consistent with Rule 144 requirements
• Acquisition details provided: shares were acquired by exercising options on 03/07/2016 with cash paid upon exercise, showing a long-held basis

Negative

• Concentrated insider selling in the prior three months (37,648 shares) which could be perceived negatively by some investors
• No 10b5-1 plan date shown in the visible filing fields, so it is unclear whether recent sales were pre-planned or opportunistic

Insights

Financial Analyst

TL;DR: Insider plans a modest Rule 144 sale after prior monthly dispositions, suggesting liquidity needs rather than a company-specific red flag.

The filing shows a proposed sale of 15,000 shares valued at roughly $2.9 million and prior sales of 37,648 shares in the past three months totaling about $9.5 million. The shares were originally acquired via option exercise in 2016, indicating a long-held position. From an analytical perspective, the planned sale size is small relative to the reported 50,773,337 shares outstanding (~0.03% for the planned sale; ~0.074% for recent sales combined), so this likely has limited direct impact on market capitalization. Investors should note the pattern of regular sell transactions by this individual but no new information on company operations or financials is included in the filing.

Corporate Governance Expert

TL;DR: Disclosure is consistent with Rule 144 requirements; signatures and representations regarding material non-public information are present.

The notice provides required broker, acquisition, and prior-sale details and includes the statutory representation that the seller is not aware of undisclosed material adverse information. The acquisition via option exercise in 2016 and cash payment upon exercise are clearly stated, supporting Rule 144 eligibility elements. While the document references Rule 10b5-1 language, no specific plan adoption date is provided in the visible fields. From a governance standpoint, the filing appears procedurally complete but does not include a 10b5-1 plan date, which would clarify whether some sales were pre-planned.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc 85 Broad St. New York NY 10004	15000	2905350.00	50773337	10/01/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	03/07/2016	Exercised Options	Issuer			851000	03/07/2016	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Zinman Eran 6 YITZHAK SADEH STREET Tel Aviv L3 677750	Ordinary	07/01/2025	12500	3799074.00
Zinman Eran 6 YITZHAK SADEH STREET Tel Aviv L3 677750	Ordinary	08/01/2025	12500	3136210.75
Zinman Eran 6 YITZHAK SADEH STREET Tel Aviv L3 677750	Ordinary	09/02/2025	3174	598527.20
Zinman Eran 6 YITZHAK SADEH STREET Tel Aviv L3 677750	Ordinary	09/08/2025	1974	376337.38
Zinman Eran 6 YITZHAK SADEH STREET Tel Aviv L3 677750	Ordinary	09/17/2025	108	21635.22
Zinman Eran 6 YITZHAK SADEH STREET Tel Aviv L3 677750	Ordinary	09/18/2025	2392	486128.55
Zinman Eran 6 YITZHAK SADEH STREET Tel Aviv, L3 677750	Ordinary	09/19/2025	5000	1090547.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for MNDY disclose?

The Form 144 discloses a proposed sale of 15,000 ordinary shares through Oppenheimer valued at $2,905,350.00, with an approximate sale date of 10/01/2025.

How many shares did the filer sell in the past three months?

The filer sold a total of 37,648 shares between July and September 2025, producing gross proceeds of $9,508,460.10.

How and when were the shares being sold originally acquired?

The disclosed shares were acquired by exercising options on 03/07/2016; the exercise covered 851,000 shares and payment was cash upon exercise.

Through which broker will the proposed sale be executed?

The filing names Oppenheimer & Co. Inc (85 Broad St., New York, NY) as the broker for the proposed sale.

Does the filing indicate any undisclosed material information?

The signer represents by certifying the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.